Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
about
iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles.Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes.Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationIL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammationDistinct T cell signatures define subsets of patients with multiple sclerosis.Neutrophils and viral-induced neurologic disease.A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.Myeloid cell plasticity in the evolution of central nervous system autoimmunity.Diagnostics of autoimmune neurodegeneration using fluorescent probing
P2860
Q30368046-383A4325-B237-4D1F-96A0-BB46CBA26005Q33834605-F8C0DD2F-3719-4F59-B2D6-EC3422F0FEA6Q33855341-A7D53602-D4AD-42FF-B8CD-85EDB8EC7FC9Q36031613-95EF2E86-80BD-450B-8573-6EDE6D2AEDE2Q36451661-F3E43F70-28D6-4490-B3BE-EFA979AD042DQ37081950-0095E594-378A-4FCC-8EB0-7D0E8A7CED11Q37201028-F337C261-7675-4CE6-A148-01391F7372F7Q38861938-FE9CAAB1-35CB-490D-BFD6-279A4E96C370Q40431064-BDFE295F-D702-4038-931E-06515B187A0BQ42364364-513AACA9-119B-4959-B3ED-E2DE36CF3A50Q47232442-22CCBFB6-7075-475E-8532-CD3B17B26FE8Q47761139-2CE090EE-C805-49A5-A23A-BFC2F35444EFQ58714753-99CB17D4-5FCA-414B-85F5-0A72AE9B35B2
P2860
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@ast
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@en
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@nl
type
label
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@ast
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@en
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@nl
prefLabel
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@ast
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@en
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@nl
P2093
P2860
P1433
P1476
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
@en
P2093
Ashok Srinivasan
David N Irani
Peisong Han
Sven Ekholm
P2860
P304
P356
10.1212/WNL.0000000000000908
P407
P577
2014-09-24T00:00:00Z